Skip to main content
. Author manuscript; available in PMC: 2015 Aug 1.
Published in final edited form as: Medchemcomm. 2014 May 16;5(8):1126–1129. doi: 10.1039/C4MD00103F

Fig. 1.

Fig. 1

(a) Anti-Tn IgG titers on days 0, 35 and 89 from mice immunized with glyco-polymer 13 and the anti-Tn IgG titers on day 35 from mice receiving the control polymer 14. (b) Anti-polymer backbone IgG titers on days 0 and 35 from mice immunized with glyco-polymer 13 and anti-polymer backbone IgG titers on day 35 from mice receiving control polymer 14. (c) Flow cytometry analysis of Jurkat cell binding by IgG antibodies in sera from representative mice immunized with glycopolymer 13 (orange curve) and control polymer 14 (blue curve). The shaded curve was from pre-immune serum binding with Jurkat cells.